Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) shares dropped 8.8% during trading on Tuesday . The company traded as low as $79.97 and last traded at $80.21. Approximately 82,870 shares were traded during trading, a decline of 47% from the average daily volume of 156,157 shares. The stock had previously closed at $87.91. Analysts […]
Isthmus Partners LLC lifted its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 4.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,347 shares of the biotechnology company’s stock after purchasing an additional 1,530 shares during the period. Isthmus Partners […]
Viking Therapeutics to Participate at Upcoming Investor Conferences prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Viking Therapeutics To Participate At Upcoming Investor Conferences menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Market OverviewThe projected growth of the Global Dyspnea Treatment Market from USD 6.3 billion in 2023 to USD 12.2 billion by 2033, at a compound annual growth rate (CAGR) of 6.8%, reflects increasing demand for treatments addressing dyspnea a common symptom associated with various respiratory diseases, heart condi.